Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A comparison of phase imaging and quantitative susceptibility mapping in the imaging of multiple sclerosis lesions at ultrahigh field.
Onset of psoriasis upon interferon beta treatment in a multiple sclerosis patient.
Alterations of the optic pathway between unilateral and bilateral optic nerve damage in multiple sclerosis as revealed by the combined use of advanced diffusion kurtosis imaging and visual evoked potentials.
Teriflunomide in multiple sclerosis: Added benefit not proven
Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
Alkali metals levels in the human brain tissue: Anatomical region differences and age-related changes.
Episode 5 with Dr. Anne Cross on the year in MS research
Data supporting the role of Fyn in initiating myelination in the peripheral nervous system.
Interferon-beta-1b protects against multiple sclerosis-induced endothelial cells apoptosis.
Compliance to fingolimod and other disease modifying treatments in multiple sclerosis patients, a retrospective cohort study.
Dimethyl fumarate inhibits the expression and function of hypoxia-inducible factor-1α (HIF-1α).
A case of multiple evanescent white dot syndrome misdiagnosed as optic neuritis: Differential diagnosis for the neurologist.
A silver lining of neuroinflammation: Beneficial effects on myelination.
Clinical experience with repository corticotropin injection in patients with multiple sclerosis experiencing mood changes with intravenous methylprednisolone: a case series.
Dimethyl Fumarate Ameliorates Lewis Rat Experimental Autoimmune Neuritis and Mediates Axonal Protection.
Genentech and Biogen Idec announce top-line results from a Phase II/III clinical trial of Rituxan in primary-progressive multiple sclerosis
EBNA1 antigen-specific CD8+ T cells in cerebrospinal fluid of patients with multiple sclerosis.
Retinyl Palmitate Supplementation Modulates T-bet and Interferon Gamma Gene Expression in Multiple Sclerosis Patients.
Synaptic pathology: a shared mechanism in neurological disease.
Will the real multiple sclerosis please stand up?
Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome.
The impact of sexual dysfunction on health-related quality of life in people with multiple sclerosis.
FOCIS 2013: Improving Human Health Through Immunology
Dimethyl fumarate-associated lymphopenia: Risk factors and clinical significance.
Patient trial of immunization to treat Alzheimer’s disease begins at Cedars-Sinai
Pages
« first
‹ previous
…
79
80
81
82
83
84
85
86
87
…
next ›
last »